Scopus Biopharm Rg
Scopus BioPharma, a clinical‑stage biopharma, targets unmet oncologic needs with its DUET platform—dual‑action STAT3/TLR9 oligonucleotides—advancing DUET‑01/02/03 therapies under City of Hope, NIH, and Hebrew University licenses.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- Employees: 13
- HQ: New York
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.